This trial is testing an investigational drug to see if it is safe to use alone or with another drug to treat people with advanced solid tumors or advanced breast cancer.
2 Primary · 5 Secondary · Reporting Duration: 48 months
Experimental Treatment
44 Total Participants · 2 Treatment Groups
Primary Treatment: CFI-402257 · No Placebo Group · Phase 1 & 2
Age 18+ · All Participants · 10 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you: